Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort

Levodopa-induced dyskinesias (LID) negatively impact on the quality of life of patients with Parkinson’s disease (PD). We assessed the risk factors for LID in a cohort of de-novo PD patients enrolled in the Parkinson’s Progression Markers Initiative (PPMI). This retrospective cohort study included a...

Descripción completa

Detalles Bibliográficos
Autores principales: Eusebi, Paolo, Romoli, Michele, Paoletti, Federico Paolini, Tambasco, Nicola, Calabresi, Paolo, Parnetti, Lucilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240081/
https://www.ncbi.nlm.nih.gov/pubmed/30480086
http://dx.doi.org/10.1038/s41531-018-0069-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240081/
https://www.ncbi.nlm.nih.gov/pubmed/30480086
http://dx.doi.org/10.1038/s41531-018-0069-x

Ejemplares similares